- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Key Biscayne Today
By the People, for the People
Reaching Weight Loss Goal on GLP-1 Meds Brings New Challenges
Experts warn of weight regain after stopping popular diabetes drugs
Apr. 11, 2026 at 11:39pm
Got story updates? Submit your updates here. ›
An X-ray view into the body's intricate weight regulation systems reveals the challenges of maintaining long-term weight loss.Key Biscayne TodayMany people who have successfully lost weight using GLP-1 medications like Ozempic and Wegovy face a new challenge - keeping the weight off once they stop taking the drugs. Experts say the body's natural tendency is to restore its former weight, leading to potential weight regain for those who discontinue these medications.
Why it matters
GLP-1 drugs have become increasingly popular for weight loss, but long-term maintenance after stopping the medications is a significant concern. Understanding the risks of weight regain can help patients and doctors develop effective strategies to sustain weight loss results.
The details
GLP-1 medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) work by mimicking a hormone that regulates appetite and blood sugar levels. This can lead to significant weight loss for many patients. However, once the medication is stopped, the body's natural tendency is to return to its previous weight set point, often resulting in weight regain.
- The article was published on April 11, 2026.
The players
GLP-1 medications
A class of drugs that mimic the glucagon-like peptide-1 (GLP-1) hormone to regulate appetite and blood sugar, leading to weight loss.
What’s next
Experts recommend that patients work closely with their healthcare providers to develop a comprehensive plan for maintaining weight loss after stopping GLP-1 medications, including lifestyle changes, continued monitoring, and potentially transitioning to other weight management approaches.
The takeaway
The success of GLP-1 medications for weight loss has been a game-changer, but the challenge of long-term weight maintenance remains. Understanding the body's natural tendency to regain weight can help patients and doctors prepare for this eventuality and develop strategies to sustain the hard-won results.


